Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
AMPH: Amphastar Pharmaceuticals, Inc. Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
AMPH
The Story
AMPH
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+13.6% / yr
Operating margin
16.2%
ROIC
6.0%
Financially safe
Strong
Debt / equity
0.89×
Interest coverage
4.5×
Current ratio
3.85×
Valuation
Unrated
P/E ratio
11.7×
Amphastar Pharmaceuticals, Inc.
AMPH
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Amphastar Pharmaceuticals, Inc.
AMPH
NASDAQ
·
USD
·
Closed
$19.94
−2.16%
$19.94
−$0.44 (2.16%)
52W Range
23th
pctl
Volume
0.59×
avg
Mkt Cap
879.21M
USD
P/E
11.7
TTM
Div Yield
–
ann
52W Range
23th
pctl
Volume
0.59×
avg
Market Cap
879.21M
USD
P/E Ratio
11.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings